2018
DOI: 10.1096/fj.201801585r
|View full text |Cite
|
Sign up to set email alerts
|

Brefeldin A–sensitive ER‐Golgi vesicle trafficking contributes to NLRP3‐dependent caspase‐1 activation

Abstract: Endoplasmic reticulum (ER)‐Golgi vesicle trafficking plays a pivotal role in the conventional secretory pathway of many cytokines; however, the precise release mechanism of a major inflammasome mediator, IL‐1β, is not thought to follow the conventional ER‐Golgi route and remains elusive. Here, we found that perturbation of ER‐Golgi trafficking by brefeldin A (BFA) treatment attenuated nucleotide‐binding oligomerization domain‐like receptor family, pyrin–domain–containing 3 (NLRP3) inflammasome activation in mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(26 citation statements)
references
References 41 publications
1
24
0
1
Order By: Relevance
“…Following treatment with NLRP3 activators, the levels of diacyl glycerol (DAG) at the Golgi increased and this coincided with the localisation of NLRP3 on MAMs adjacent to the Golgi 20 . Disruption of Golgi integrity with brefeldin A reduced caspase-1 activation, IL-1β secretion and ASC speck formation following NLRP3 inflammasome activation, a result which was corroborated in a subsequent study 94 . This effect was attributed to protein kinase D (PKD), a DAG effector, which phosphorylated NLRP3 at a conserved residue (Ser293) in its NBD domain, allowing its release from MAMs to form an inflammasome complex within the cytosol ( Figure 2).…”
Section: The Golgi Complexsupporting
confidence: 72%
“…Following treatment with NLRP3 activators, the levels of diacyl glycerol (DAG) at the Golgi increased and this coincided with the localisation of NLRP3 on MAMs adjacent to the Golgi 20 . Disruption of Golgi integrity with brefeldin A reduced caspase-1 activation, IL-1β secretion and ASC speck formation following NLRP3 inflammasome activation, a result which was corroborated in a subsequent study 94 . This effect was attributed to protein kinase D (PKD), a DAG effector, which phosphorylated NLRP3 at a conserved residue (Ser293) in its NBD domain, allowing its release from MAMs to form an inflammasome complex within the cytosol ( Figure 2).…”
Section: The Golgi Complexsupporting
confidence: 72%
“…This is consistent with our observation that GCA treatment prevents IL‐1β release from AM‐MDMs following treatment with NLRP3 activators or F. tularensis infection. A number of reports show that NLRP3 inflammasome formation depends on trafficking of Golgi‐associated vesicles, although different studies have placed these vesicles at the ER‐Golgi interface [55], between mitochondria‐associated membranes and the Golgi [54], or emerging from a dispersed trans ‐Golgi network [56]. Interestingly, differences are apparent between macrophage models: brefeldin A treatment blocked NLRP3‐mediated caspase‐1 cleavage and IL‐1β release in BMDMs but not in human monocytes or THP‐1 cells, nor did it affect activation of the AIM2 or NLRC4 inflammasomes [55].…”
Section: Discussionmentioning
confidence: 99%
“…The significant role of Golgi apparatus in NLRP3 inflammasome activation has gradually been recognized. Disruption of ER‐Golgi trafficking inhibited NLRP3 inflammasome assembly and caspase‐1 activation, indicating the involvement of ER‐Golgi vesicle trafficking in NLRP3 activation 11 . Furthermore, NLRP3 inflammasome activation was reported to be accompanied by mitochondrial clustering around the Golgi.…”
Section: Mechanism Underlying Nlrp3 Inflammasome Activationmentioning
confidence: 98%